The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancer
- 15 March 1986
- Vol. 57 (6) , 1105-1109
- https://doi.org/10.1002/1097-0142(19860315)57:6<1105::aid-cncr2820570607>3.0.co;2-w
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Chemotherapy strategies in squamous cell carcinoma of the head and neckCritical Reviews in Oncology/Hematology, 1984
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neckCancer, 1984
- Adjuvant chemotherapy with Cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neckCancer, 1983
- A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancerCancer, 1981
- Chemotherapy of Head and Neck CancerOtolaryngologic Clinics of North America, 1980
- Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancerCancer, 1979
- Adjuvant Methotrexate and Leucovorin in Head and Neck Squamous Cancer: Two-year Follow-up of a Pilot ProjectJAMA Otolaryngology–Head & Neck Surgery, 1978
- Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinumThe American Journal of Surgery, 1978
- An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tractsCancer, 1977
- Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinomaCancer, 1975